EquiCord is a multidisciplinary company formed by veterinarians, researchers and engineers dedicated to the research & development, manufacturing and commercialization of Stem Cell based medicines for animals. In 2019, we obtained the European Marketing Authorization of the fisrt and unique pure Mesenchymal Stem Cell veterinary medicine worldwide: HorStem. Recently , we submitted for centralized MA, DogStem, the first Stem Cell based medicine for the treatment of pain and lameness in canine OA. EquiCord's mission is to develop afforable, innovative, highly effective, safe and regenerative advanced therapies medicines available to all the animals worldwide. Our regulatory department is preparing the expansion of HorStem and DogStem to the USA, Middle East, Asia and Latin America. We offer our services on a global basis with maximum efficiency and quality standards.